Therapeutic effects of micronutrient supplements on sperm parameters: Fact or Fiction?

Abstract:

BACKGROUND:Despite the limited evidence about the effect of micronutrient supplementation on the semen quality, many micronutrient supplements have been used to improve male fertility. Approximately, 40%-50% of male infertility cases in general and up to 80% in men with idiopathic infertility cases are caused by oxidative stress and decreased level of seminal total antioxidant capacity. OBJECTIVE:To investigate the beneficial effects of micronutrient supplementation on sperm concentration, motility and morphology. METHODS:A Pub Med, Google Scholar, Embase data, web of Science and Cochrane Library database extensive research of the randomized controlled studies utilizing micronutrient vitamins and supplements was performed. RESULTS:The existent international literature is rather heterogeneous and a definitive is difficult to be drawn. Several micronutrients have beneficial effects on sperm parameters. Rational use of micronutrients might be helpful for infertile patients. CONCLUSION:Further randomized, controlled clinical trials are required to elucidate the efficacy and safety of micronutrients and propose proper protocols for their use. A well-rounded, balanced diet is more preferable than the widespread use of micronutrient supplements beyond the recommended doses. Future studies should concern the pregnancy rate as a primary outcome in their designs. Further research should be done to determine the appropriate antioxidant compounds, the duration of the treatment, as well as a certain dose of antioxidants in clinical practices. The pre-treatment evaluation of the seminal oxidative status is also an important parameter to proceed with micronutrient supplementation without the risk of reductive stress. Under these conditions, supplements could support the quality of sperm and help to alleviate male infertility.

journal_name

Curr Pharm Des

authors

Dimitriadis F,Tsounapi P,Zachariou A,Kaltsas A,Sokolakis I,Hatzichristodoulou G,Symeonidis EN,Kotsiris D,Gabales MR,Vlachopoulou E,Takenaka A,Sofikitis N

doi

10.2174/1381612826666200415173537

subject

Has Abstract

pub_date

2020-04-15 00:00:00

eissn

1381-6128

issn

1873-4286

pii

CPD-EPUB-105846

pub_type

杂志文章
  • Carnitine palmitoyltransferase: a viable target for the treatment of NIDDM?

    abstract::Inhibition of fatty acid oxidation is well recognized as a potentially effective mechanism for controlling glycemia in non-insulin-dependent diabetes mellitus (NIDDM). However, a direct targeting of inhibition of the intramitochondrial beta-oxidation pathway or an indirect modulation of fatty acid oxidation by inhibit...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:

    authors: Anderson RC

    更新日期:1998-02-01 00:00:00

  • Hypersensitivity reactions to neuromuscular blocking agents.

    abstract::Neuromuscular blocking agents are the leading drugs responsible for immediate hypersensitivity reactions during anaesthesia. Most hypersensitivity reactions represent IgE-mediated allergic reactions. Their incidence is estimated to be between 1 in 3,000 to 1 in 110,000 general anaesthetics. However striking variations...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/138161208786369704

    authors: Mertes PM,Aimone-Gastin I,Guéant-Rodriguez RM,Mouton-Faivre C,Audibert G,O'Brien J,Frendt D,Brezeanu M,Bouaziz H,Guéant JL

    更新日期:2008-01-01 00:00:00

  • The Applications of 3D Printing in Pulmonary Drug Delivery and Treatment of Respiratory Disorders.

    abstract:BACKGROUND:Pulmonary diseases are the third leading cause of morbidity worldwide, however treatment and diagnosis of these diseases continue to be challenging due to the complex anatomical structure as well as physiological processes in the lungs. METHODS:3D printing is progressively finding new avenues in the medical...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612825666181206123414

    authors: Haque S,Md S,Whittaker M,Kaminskas LM

    更新日期:2018-01-01 00:00:00

  • RNAi in Plasmodium.

    abstract::RNA interference (RNAi) has quickly proven to be an immensely useful tool for studying gene function and validation of potential drug targets in almost all organisms that possess the required set of proteins of the interference pathway. In protozoan parasites like Plasmodium, Toxoplasma, Entamoeba, Giardia, Trypanosom...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/13816128113199990027

    authors: Mueller AK,Hammerschmidt-Kamper C,Kaiser A

    更新日期:2014-01-01 00:00:00

  • When ubiquitin meets NF-κB: a trove for anti-cancer drug development.

    abstract::During the last two decades, the studies on ubiquitination in regulating transcription factor NF-κB activation have elucidated the expanding role of ubiquitination in modulating cellular events by non-proteolytic mechanisms, as well as by proteasomal degradation. The significance of ubiquitination has also been recogn...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612811319180010

    authors: Wu ZH,Shi Y

    更新日期:2013-01-01 00:00:00

  • Enantiodiscrimination by NMR spectroscopy.

    abstract::The analysis of enantiorecognition processes involves the detection of enantiomeric species as well as the study of chiral discrimination mechanisms. In both fields Nuclear Magnetic Resonance (NMR) spectroscopy plays a fundamental role, providing several tools, based on the use of suitable chiral auxiliaries, for obse...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/138161206778743628

    authors: Uccello-Barretta G,Balzano F,Salvadori P

    更新日期:2006-01-01 00:00:00

  • Role of copper in prion diseases: deleterious or beneficial?

    abstract::Prion diseases are fatal neurodegenerative disorders associated with conformational conversion of the cellular prion protein (PrP(C)) into an isoform designated PrP(Sc). The pathogenic mechanism that links this conformational distortion with the development of prion diseases is unknown. PrP(C) is a GPI-anchored cell s...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/138161206777698873

    authors: Varela-Nallar L,González A,Inestrosa NC

    更新日期:2006-01-01 00:00:00

  • Involvement of the transforming growth factor beta in the pathogenesis of hereditary hemorrhagic telangiectasia.

    abstract::Hereditary hemorrhagic telangiectasia (HHT) is characterized by vessel alterations such as dilatation of postcapillary venules and arterio-venous communications, which account for the major clinical manifestations of the disease. Two types of HHT have been characterized HHT-1 and HHT-2, respectively, depending the for...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/138161206776361228

    authors: Jirillo E,Amati L,Suppressa P,Cirimele D,Guastamacchia E,Covelli V,Tafaro E,Sabbà C

    更新日期:2006-01-01 00:00:00

  • Radioimmunotherapy of cancer: using monoclonal antibodies to target radiotherapy.

    abstract::After years of pre-clinical and clinical testing monoclonal antibodies (mAbs) finally offer new therapeutic choices for patients with haematological and solid malignancies both as unconjugated antibody and as vectors to target radionuclides in radioimmunotherapy (RIT). In recent years some of the most exciting clinica...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612003399257

    authors: Illidge TM,Brock S

    更新日期:2000-09-01 00:00:00

  • Recent Advances in Non-Invasive Delivery of Macromolecules using Nanoparticulate Carriers System.

    abstract:BACKGROUND:The drug delivery of macromolecules such as proteins and peptides has become an important area of research and represents the fastest expanding share of the market for human medicines. The most common method for delivering macromolecules is parenterally. However parenteral administration of some therapeutic ...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612822666161026163201

    authors: Shadab M,Haque S,Sheshala R,Meng LW,Meka VS,Ali J

    更新日期:2017-01-01 00:00:00

  • Expression of Rab3b in Human Glioma: Influence on Cell Proliferation and Apoptosis.

    abstract:BACKGROUND:Glioma is the most common human central nervous system tumour with a high degree of malignancy. Some Rab GTPases have significant effects on glioma. OBJECTIVE:This study aimed to investigate the effect of Rab3b (Rab GTPase3b) on human glioma cell proliferation and apoptosis by silencing Rab3b and to initial...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章

    doi:10.2174/1381612826666200917145228

    authors: Luo Q,Liu Y,Yuan Z,Huang L,Diao B

    更新日期:2020-09-17 00:00:00

  • An Update on the Immunological, Metabolic and Genetic Mechanisms in Drug Hypersensitivity Reactions.

    abstract::Drug hypersensitivity reactions (DHRs) represent a major burden on the healthcare system since their diagnostic and management are complex. As they can be influenced by individual genetic background, it is conceivable that the identification of variants in genes potentially involved could be used in genetic testing fo...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612825666191105122414

    authors: Mayorga C,Montañez MI,Jurado-Escobar R,Gil-Ocaña V,Cornejo-García JA

    更新日期:2019-01-01 00:00:00

  • Cingulate volume abnormalities in emerging psychosis.

    abstract:BACKGROUND:Neuroanatomical abnormalities, including cingulate cortex volume abnormalities, are a common feature in psychosis. However, the extent to which these are related to a vulnerability to psychosis, as opposed to the disorder per se, is less certain. AIM UND HYPOTHESES: The aim of the present study is to compare...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章

    doi:10.2174/138161212799316316

    authors: Röthlisberger M,Riecher-Rössler A,Aston J,Fusar-Poli P,Radü EW,Borgwardt S

    更新日期:2012-01-01 00:00:00

  • Toll-like receptors in human infectious diseases.

    abstract::Toll-like receptors (TLRs) have emerged as critical players in immunity. They are capable of sensing organisms ranging from protozoa to bacteria, fungi or viruses upon detection of the pathogen as well as recognizing endogenous ligands, and triggering transduction pathways. Following activation of the innate immune sy...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/138161206778743493

    authors: de la Barrera S,Alemán M,Sasiain Mdel C

    更新日期:2006-01-01 00:00:00

  • Neuroinflammation: A Therapeutic Target of Cotinine for the Treatment of Psychiatric Disorders?

    abstract::Neuroinflammation is a common characteristic of several mental health conditions such as major depression, bipolar disorder, post-traumatic stress disorder (PTSD) and schizophrenia (SCHZ). Inflammatory processes trigger and/or further deteriorate mental functions and are regarded as targets for therapeutic drug develo...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/138161282210160304112511

    authors: Echeverria V,Grizzell JA,Barreto GE

    更新日期:2016-01-01 00:00:00

  • Systemic sclerosis-related pulmonary hypertension: unique characteristics and future treatment targets.

    abstract::Pulmonary arterial hypertension (PAH) is a severe vascular complication of connective tissue diseases. In the context of systemic sclerosis (SSc), PAH is a devastating disease with a dramatic impact on prognosis and survival. Despite advances in early diagnosis and the development of new targeted treatments, SSc-relat...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/138161212799504704

    authors: Dimitroulas T,Giannakoulas G,Karvounis H,Settas L,Kitas GD

    更新日期:2012-01-01 00:00:00

  • High-throughput screening identifies small molecule inhibitors of molecular chaperones.

    abstract::Heat shock proteins (HSPs) are involved in a number of cellular processes, including cell cycle, growth, and survival, apoptosis, stress responses, angiogenesis, and oncogenesis. Among the characterized HSPs, the molecular chaperone HSP90 has emerged as an exciting molecular target for cancer therapy since its discove...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:

    authors: Kondoh Y,Osada H

    更新日期:2013-01-01 00:00:00

  • Apolipoprotein E knockout models.

    abstract::Atherosclerosis is a multifactorial and long-lasting process in humans. Therefore, animal models where more rapid changes occur can be useful for the study of this process. Among such models are the apolipoprotein (apo) E knock out mice. Apo E deficient mice show impaired clearing of plasma lipoproteins and they devel...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/138161208783497769

    authors: Kolovou G,Anagnostopoulou K,Mikhailidis DP,Cokkinos DV

    更新日期:2008-01-01 00:00:00

  • The role of blood-brain barrier transporters in pathophysiology and pharmacotherapy of stroke.

    abstract::Cerebral ischemia is one of the major causes of disability worldwide. In cerebral ischemic stroke, occlusion of a major cerebral artery by an embolus or local thrombosis can result in transient or permanent reduction of cerebral blood flow to a portion of the brain, resulting in deprivation of glucose and oxygen. Sinc...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/13816128113199990465

    authors: Shah K,Abbruscato T

    更新日期:2014-01-01 00:00:00

  • Genomes to hits in silico - a country path today, a highway tomorrow: a case study of chikungunya.

    abstract::These are exciting times for bioinformaticians, computational biologists and drug designers with the genome and proteome sequences and related structural databases growing at an accelerated pace. The post-genomic era has triggered high expectations for a rapid and successful treatment of diseases. However, in this bio...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/13816128113199990379

    authors: Soni A,Pandey KM,Ray P,Jayaram B

    更新日期:2013-01-01 00:00:00

  • P2-pyrimidinergic receptors and their ligands.

    abstract::Pyrimidine nucleotides, including UTP, UDP and UDP-glucose, are important signaling molecules which activate G protein-coupled membrane receptors of the P2Y family. Four distinct pyrimidine nucleotide-sensitive P2Y receptor subtypes have been cloned, P2Y(2), P2Y(4), P2Y(6) and P2Y(14). Pharmacological experiments indi...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612023392937

    authors: Müller CE

    更新日期:2002-01-01 00:00:00

  • Druggable orthosteric and allosteric hot spots to target protein-protein interactions.

    abstract::Drug designing targeting protein-protein interactions is challenging. Because structural elucidation and computational analysis have revealed the importance of hot spot residues in stabilizing these interactions, there have been on-going efforts to develop drugs which bind the hot spots and out-compete the native prot...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/13816128113199990073

    authors: Ma B,Nussinov R

    更新日期:2014-01-01 00:00:00

  • Recent Updates in the Computer Aided Drug Design Strategies for the Discovery of Agonists and Antagonists of Adenosine Receptors.

    abstract:: ...

    journal_title:Current pharmaceutical design

    pub_type: 社论

    doi:10.2174/1381612825999190515120510

    authors: Deb PK

    更新日期:2019-01-01 00:00:00

  • Imaging the glutamate system in humans: relevance to drug discovery for schizophrenia.

    abstract::There is growing evidence for the involvement of glutamatergic abnormalities in schizophrenia. Uncompetitive NMDA receptor (NMDAR) antagonists induce effects closely resembling both the positive and negative symptoms of schizophrenia; candidate risk genes for schizophrenia converge on the NMDAR expressing synapse; and...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/138161209788957438

    authors: Stone JM

    更新日期:2009-01-01 00:00:00

  • Is there a role for cytokine based therapies in fibromyalgia.

    abstract::Cytokines are glycoproteins that serve as chemical messengers between cells. They assist in the regulation of cell growth and repair and also have immune modulating properties. Cytokines play a role in diverse clinical processes and phenomena such as fatigue, fever, sleep, pain, stress and aching. A review of the fibr...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:

    authors: Wallace DJ

    更新日期:2006-01-01 00:00:00

  • Neuroprotection with the Endozepine Octadecaneuropeptide, ODN.

    abstract::The term endozepines designates a family of astroglia-secreted proteins including the diazepambinding inhibitor (DBI) and its processing products, which have been originally isolated and characterized as endogenous ligands of benzodiazepine receptors. It is now clearly established that the octadecaneuropeptide ODN (DB...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612824666181112111746

    authors: Masmoudi-Kouki O,Hamdi Y,Ghouili I,Bahdoudi S,Kaddour H,Leprince J,Castel H,Vaudry H,Amri M,Vaudry D,Tonon MC

    更新日期:2018-01-01 00:00:00

  • Role of neurotrophins in spinal plasticity and locomotion.

    abstract::Synaptic transmission through descending motor pathways to lumbar motoneurons and then to leg muscles is essential for walking in humans and rats. Spinal cord injury (SCI), even when incomplete, results in diminished transmission to motoneurons and very limited recovery of motor function. Neurotrophins have emerged as...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/13816128113199990378

    authors: Arvanian V

    更新日期:2013-01-01 00:00:00

  • Regulation of angiogenesis by the kallikrein-kinin system.

    abstract::High molecular weight kininogen (HK) is a plasma protein that is cleaved by plasma kallikrein in the clinical settings of sepsis and chronic inflammatory diseases such as rheumatoid arthritis and Crohn's disease. This proteolytic event results in a nonapeptide, bradykinin (BK), and a kinin-free derivative of HK, namel...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/138161206777698710

    authors: Colman RW

    更新日期:2006-01-01 00:00:00

  • Importance of ABC Transporters in Drug Development.

    abstract::ATP-binding cassette (ABC) transporters are a huge family of ATP-dependent transmembrane proteins whose main function is exporting or importing substances or molecules through the cell membranes, plasma cell membrane, or inner membranes in organelles. They fulfill these functions by maintaining cell integrity, metabol...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612822666160810120359

    authors: Benadiba M,Maor Y

    更新日期:2016-01-01 00:00:00

  • Endothelial Progenitor Cells as a Therapeutic Approach for Intracerebral Hemorrhage.

    abstract:BACKGROUND:Intracerebral hemorrhage (ICH) is the most lethal subtype of stroke, a leading cause of death and disability in developed countries. Therapeutic options are notably limited. There is no specific pharmacological treatment, and early surgery has few indications that represent only a small clinically relevant s...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612822666161221153937

    authors: Pías-Peleteiro J,Campos F,Perez-Mato M,Lopez-Arias E,Rodriguez-Yanez M,Castillo J,Sobrino T

    更新日期:2017-01-01 00:00:00